Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis
Our analysis, although limited by a small sample size and a short-term follow-up period, offers suitable data on commonly used biological agents and their safety, interruption rate, and the attendance of SAEs. Real-world studies should be carried out to evaluate other safety interests.
Authors
- Luca Gallelli (ORCID: https://orcid.org/0000-0003-0858-7902)
- Caterina De Sarro (ORCID: https://orcid.org/0000-0002-3596-0090)
- Stefano Ruga (ORCID: https://orcid.org/0009-0008-0401-4027)
- Caterina Palleria
- Lorenza Guarnieri (ORCID: https://orcid.org/0009-0007-5865-8779)
- Francesca Bosco (ORCID: https://orcid.org/0009-0004-4766-9710)
- Luca Costantino (ORCID: https://orcid.org/0000-0001-5334-8084)
- Antonio Leo (ORCID: https://orcid.org/0000-0002-0061-1608)
- Antonio Aparecido Fabiano (ORCID: https://orcid.org/0000-0003-0342-5488)
- Rita Citraro (ORCID: https://orcid.org/0000-0001-6746-6751)
- Giovambattista De Sarro (ORCID: https://orcid.org/0000-0002-7629-6579)
- Chiara Verduci
- Agnese Gagliardi (ORCID: https://orcid.org/0000-0002-1795-6629)
- Vincenzo Rania (ORCID: https://orcid.org/0000-0002-9938-5259)
- Ashour Michael
Institutions
- Magna Graecia University (IT)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2024-10-14
- DOI
- https://doi.org/10.3390/pharmaceutics16101329
- Citations
- 2
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.48
Funders
- Agenzia Italiana del Farmaco, Ministero della Salute